Lobe Sciences Ltd. (LOBEF)
OTCMKTS
· Delayed Price · Currency is USD
0.0022
-0.0200 (-90.09%)
May 16, 2025, 4:00 PM EDT
Lobe Sciences Revenue
In the fiscal year ending August 31, 2024, Lobe Sciences had annual revenue of 136.21K CAD, down -83.80%.
Revenue
136.21K CAD
Revenue Growth
-83.80%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
3.27M USD
Revenue Chart
* This company reports financials in CAD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.73B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 70.00M |
| Glass House Brands | 215.62M |
| Northwest Biotherapeutics | 1.47M |
| American Oncology Network | 1.76B |
| BioStem Technologies | 332.45M |
Lobe Sciences News
- 4 weeks ago - Lobe Sciences Ltd. Announces Private Placement to Support Drug Development of Novel Conjugated Psilocin(TM) - Accesswire
- 6 weeks ago - Lobe Sciences Provides Corporate Update - Accesswire
- 6 months ago - Lobe Sciences and Alera Pharma Announce Notice of Allowance for Second U.S. Patent for Conjugated Psilocin™ - Business Wire
- 7 months ago - Lobe Sciences, Ltd. Announces the Appointment of Enclave Capital and Peak Asset Management to Fund Clinical Trials of Conjugated Psilocin™ - Business Wire
- 8 months ago - Lobe Sciences and Alera Pharma Announce Issuance of U.S. Patent for Conjugated Psilocin™ - Business Wire
- 9 months ago - Lobe Sciences Announces Creation of Wholly Owned Subsidiary, Alera Pharma, Inc. - Business Wire
- 9 months ago - Lobe Sciences Announces Appointment of a New Board of Directors and Executive Management Team - Business Wire
- 1 year ago - Lobe Sciences Announces Update - Business Wire